SlideShare une entreprise Scribd logo
1  sur  55
Aboubakr Elnashar
Benha university Hospital, Egypt
Aboubakr Elnashar
Patterns of foetal activity
1.Fetal breathing movements
2.Gross body movements
3.Fine motor movements
Aboubakr Elnashar
During the last 10 w of pregnancy:
F. breathing movements: 30% of the time
Gross body movements: 10% of the time
At term:
Cycling between activity & quiescence: occurs
over a time span of 60 min
Activity is highest: in late evening
FHR variation: increases during fetal activity
f. body movements: FH acceleration
Aboubakr Elnashar
Adaptations to hypoxia
 Early
1.Reduced FHR reactivity
2.Absence of breathing movements
 Late:
1. Reduced body movements and tone
2. Reduced liquor (renal hypoperfusion)
Aboubakr Elnashar
Aboubakr Elnashar
The ideal test
1. Quick
2. Easy to perform
3. Interpreted results that are reproducible.
4. Clearly identify the compromised fetus at a
stage at which intervention will improve the
outcome
5. Not give an abnormal result for a healthy fetus.
 Unfortunately, this ideal test does not yet exist!
Aboubakr Elnashar
I. Fetal movements counting (FMC)
II. FHR recording
1.CTG
2.Non-Stress Test (NST)
3.Contraction StressTest (CST) or Oxytocin Challenge
Test (OCT)
4.Nipple stimulation test
5.Vibroacoustic stimulation (VAS)
6.Computerized CTG
III. Biophysical Profile (BPP)
IV. Doppler
Aboubakr Elnashar
FHR recording
1.CTG
2.NST
3.Contraction stress test
4.Nipple stimulation test
5.Acoustic stimulation test
6.Computerized CTG
Aboubakr Elnashar
1. FHR tracings (CTG)
METHOD
Simultaneous recordings are performed by 2
separate transducers:
1st for FHR
2nd for UC
Aboubakr Elnashar
INTERPRETATION
1.Normal/Reassuring
Trace
 Baseline FHR: 110-150
b/m
 Baseline variability: 10-
25 b/m
 At least 2 accelerations
(>15 beats for> 15 sec in
20 min)
 No decelerations.
Aboubakr Elnashar
2. Suspicious/Equivocal Trace.
 Baseline FHR: 150-170 b/m or 100-110 b/m
 Reduced baseline variability (5-10 b/m for >40 m)
 Absence of accelerations for >40 m
 Sporadic deceleration of any type.
 absence of
accelerations
 diminished variability
 late decelerations with
weak spontaneous
contractions. Aboubakr Elnashar
Aboubakr Elnashar
Abnormal/Pathological Trace -
 Baseline FHR: <100 b/m or > 170 b/m
 No area of normal baseline variability
 Silent Pattern (<5 b/m) for >40 min
 Sinusoidal pattern (oscillation frequency = 2-5
cycles/min, amplitude of 5-15 b/m) for >40 m
 No accelerations
 Repeated
late,
prolonged (> 1 minute)
severe variable* (>40 b/m) decelerations.
 *decelerations vary in depth, vary in duration and vary in
timing relative to the uterine activity
Aboubakr Elnashar
Tachycardia
 Sinusoidal pattern
 Late deceleration
normal baseline rate at 120
bpm,
absent baseline variability,
no accelerations
late decelerations
Aboubakr Elnashar
 variable fetal heart rate decelerations.
Reassuring shoulders (accelerations) are
obvious before and after each
deceleration.
baseline tachycardia
minimal variability.
Aboubakr Elnashar
MANAGEMENT:
 Normal/Reassuring Trace –
repeat and/or estimate AFI if considered necessary
acc to the cl situation and indication for testing.
 Suspicious/Equivocal Trace –
 Continue for up to 60 min {determine the
presence of f rest/activity cycles}.
 Further evaluation acc to the cl situation e.g. fetal
acoustic stimulation, AFI, BPP, Doppler blood
velocity waveform.
 Abnormal/Pathological Trace –
 deliver if clinically appropriate.
 Further evaluation/monitoring if not appropriate to
deliver.
Aboubakr Elnashar
Advantages:
It is the most commonly
performed antenatal test for
fetal wellbeing.
Quick
Simple to perform
Aboubakr Elnashar
2. The Non-Stress Test (NST)
(Hammacher et al, 1960)
Idea:
• FHR accelerations:
linked closely with f movements
{increased sympathetic output}.
• The long term variability:
{balance between sympathetic &
parasympathetic tone}
• The short term variability
(baseline or bandwidth variability)
{parasympathetic tone}.
Aboubakr Elnashar
Steps:
1. left lateral recumbent position.
2. Place and adjust the external
tocodynamometer and US
transducer to obtain the best
possible tracing.
3. Instruct the patient to record f
movements on the monitor
tracing using the event marker.
4. Observe the EFM tracing until
the criteria for a reactive test are
met
(minimum of 20 min and maximum
of 60 min). Aboubakr Elnashar
 In the event of lack of f movement, apply
stimulation e.g. fetal acoustic stimulator.
 Record any relevant clinical information on the
EFM tracing e.g.
BP
T
P
loss of contact
changes in maternal position.
Aboubakr Elnashar
Interpretation:
 Reactive:
2 accelerations of FHR in 20 min.
Each acceleration 15 beat & lasts 15 sec.
 Non-reactive:
no accelerations in 40 min.
Aboubakr Elnashar
•Reactive:
increase of FHR to >15 beats/min for
> 15 sec following fetal movements
Reactive
Aboubakr Elnashar
Antenatal maternal glucose administration:
not to reduce non-reactive CTG
(Cochrane , 2001)
Manual fetal manipulation:
not to reduce the incidence of non-reactive CTG.
(Cochrane , 2001)
Reactive nonstress
reliable screening indicator of f wellbeing in
women presenting with perception of RFM in 3rd T
Abnormal pregnancy outcomes:
more common when initial CTG was non reactive
(Daly et al, 2011)
Aboubakr Elnashar
Disadvantages:
1. Interpretation may be difficult &
poor agreement between experts
in assessing CTG
2. The predictive value of an abnormal
NST for perinatal morbidity &
mortality:<40%
(Devoe et al, 1985)
Aboubakr Elnashar
3. No significant effect on perinatal
outcome
(MA of 13 trials)
Trend towards increased perinatal
mortality (SR of 4 RCT)
(Cochrane library, 2001)
NST should not be relied upon as
the sole means of establishing f
wellbeing {Ia}
Aboubakr Elnashar
3. The Contraction Stress Test (CST) or
Oxytocin Challenge Test (OCT)
1972: First introduced by Ray
1975: Freeman introduced the parameters of
contraction number and frequency to standardize
the test.
Aboubakr Elnashar
Idea:
It is a test of the
uteroplacental unit.
If fetal oxygenation is
marginal at rest, it will
transiently worsen with uterine
contractions: hypoxemia: late
decelerations.
If variable decelerations
were seen, one should
suspect oligohydramnios.
Aboubakr Elnashar
Steps:
Semi-fowlers position.
If the patient is not having spontaneous
contractions, pitocin is begun at 0.5-1.0 mU and
increased /15-20 minutes until 3C/10 min.
Aboubakr Elnashar
Interpretation:
Negative:
no decelerations with the 3 contractions in
the 10 minute window.
Positive:
late decelerations with 50% or more of the
contractions.
Suspicious:
intermittent late decelerations or severe
variable deceleration.
Unsatisfactory:
<3 contractions or hyperstimulation.
Aboubakr Elnashar
•Non-reactive NST followed by CST:
mild late decelerations.
Aboubakr Elnashar
CST: negative
Aboubakr Elnashar
1. Negative
No deceleration
2. Positive
transient
decelerations
Aboubakr Elnashar
Relative contraindications:
1. Preterm labor or certain patients at
high risk of preterm labor
2. Preterm membrane rupture
3. History of extensive uterine surgery
or classical cesarean delivery
4. Known placenta previa
Aboubakr Elnashar
The role of this technique
has yet to be established
it has been associated with reports of fetal
death in cases of unrecognized severe fetal
compromise [E].
Aboubakr Elnashar
Sequence Of Events With Placental
Insufficiency or Hypoxia
1. Positive CST= late deceleration in 50% of UC.
2. Non reactive NST= No HR acceleration
3. Cessation of fetal movement
4. Basal line tachycardia > 160 bpm
5. Basal line bradycardia <110 bpm
Aboubakr Elnashar
5. VIBROACOUSTIC STIMULATION (VAS)
Idea:
Vibroacoustic stimulator wakes a sleeping fetus:
changing its behavioral state.
How to perform:
Artificial larynxes that generate sound pressure
levels of approximately 80 to 100 decibels is
applied in two or three one-second bursts to the
maternal abdomen near the fetal head.
Aboubakr Elnashar
Advantages:
1. Easy, relatively inexpensive way
to shorten testing times and reduce
the false-positive rates for NST &
biophysical profiles.
2. Fetuses that respond to VAS
with an acceleration on NST or a
startle response on FBP: very low
rates of death within one week of
the test.
3. Decrease the incidence of non-
reactive CTG and reducing the
testing time (The Cochrane Database of
Systematic Review, 2001)
Aboubakr Elnashar
6. Computerized CTG
• To improve the objectivity of antenatal CTG
• The program unlike conventional CTG, allows
measurement of short term variability (STV).
• STV=variation measured in 3.75 s epochs.
• FHRV: better predictor of fetal compromise than the
acceleration or decelerations.
• Likelihood of metabolic acidaemia or IUFD can be
calculated according to the STV.
Aboubakr Elnashar
Aboubakr Elnashar
Conventional Vs computerized CTG
1.Fewer additional fetal tests
2.Less time in testing.
3.The study was not large enough to
demonstrate any effect on perinatal
morbidity or mortality.
Aboubakr Elnashar
III. The Biophysical Profile (BPP)
First described by Manning in 1980.
Idea:
Sequence of fetal deterioration
1. Late decelerations appear (CST)
2. Accelerations disappear (NST, BPP, CST)
3. F breathing stops (BPP)
4. F movement stops (BPP)
5. F tone absent (BPP)
6. A F decreases {chronic hypoxia: redistribution of cardiac
output away from the kidneys toward the brain}: AFV is a quick
evaluation of long term uteroplacental function as in the late
2nd and all the 3rd trimester {AF is essentially fetal urine}.
Aboubakr Elnashar
OBSERVATION CRITERIA FOR
PRESENT
CRITERIA FOR
NEGATIVE
F Tone 1 episode of flexion-
extension-flexion in 30
min
No episodes of flexion-
extension-flexion in 30
minutes
F Movement 3 gross body
movements in 30
min
Less than 3 gross body
movements in 30 minutes
F Breathing 1 episode of
rhythmic breathing
in 30 min
No episodes of rhythmic
breathing in 30 minutes
A FV One 2 centimeter pocket
measured in two
perpendicular planes
A pocket measuring
less than 2
centimeters
NST Reactive test Non-reactive test
Two points are given if the observation is present and zero points are given if it is
absent.
Aboubakr Elnashar
Interpretation:
8:
reassuring.
6:
equivocal: repeat within 24 h.
4 or less:
positive test: strongly suggests preparing
the patient for delivery.
Aboubakr Elnashar
Modifications
1. BPP Manning (1990)
NST
AFV
Fetal breathing.
less cumbersome
results are just as predictive.
Aboubakr Elnashar
2. Placental grading
has been incorporated in the BPP to give an
overall score out of 12 rather than 10.
Aboubakr Elnashar
3. The most powerful components:
•AFI:
indicator of long term uteroplacental function
•NST:
short term indicator of fetal acid-base status.
assessment of fetal well-being using these two
tools alone may well be as effective as formal BPP
Aboubakr Elnashar
 Advantages:
1. In high-risk:
 observational studies: effective
 {good negative predictive value (99.9%)
i.e. fetal death is rare in women with a
normal FBP
 rarely abnormal when Doppler findings
were normal}.
Aboubakr Elnashar
2. In pre-labour rupture of the
membranes
{fetal breathing movements is reduced
in the presence of chorioamnionitis}
But sensitivity for abnormal BPP in the
presence of chorioamnionitis is
25%[B]: value of BPP is limited
Aboubakr Elnashar
 Disadvantages:
1. Difficult and time-consuming
2. False-positive rate: 70%: increased rates of
unnecessary intervention.
3. Systematic review of five RCTs: failed to
demonstrate any significant benefit of BPP on
pregnancy outcome when compared to NST
Aboubakr Elnashar
4. In low risk: cannot be recommended for routine
monitoring
5. In high Risk: positive predictive value of 35%
(observational study)
No enough evidence from RCTs
(Cochrane Systematic Review, 2000).: cannot be recommended for
routine monitoring for primary surveillance in SGA
Aboubakr Elnashar
Statistical Characteristics of Selected
Antepartum Fetal Tests
Characteristic NST CST BPP
Specificity Poor Average High
Specificity High High High
False-positive rate High High High
False-negative rate Low Low Average
Aboubakr Elnashar
CONCLUSIONS
Aboubakr Elnashar
1. CTG, must not form the sole basis for the
assessment of the fetus.
2. Computerized CTG may well be more effective
than standard CTG.
3. Formal assessment of the BPP does not
appear to hold any advantage over
assessment of liquor volume alone.
4. Where fetal growth restriction is suspected,
fetal biometry and assessment of umbilical
artery waveforms by Doppler ultrasonography
should be incorporated.
Aboubakr Elnashar
Aboubakr Elnashar
Aboubakr Elnashar

Contenu connexe

Tendances

CTG Interpretation .pptx
CTG Interpretation .pptxCTG Interpretation .pptx
CTG Interpretation .pptxWafaa Benjamin
 
Antepartum Fetal Surveillance
Antepartum Fetal SurveillanceAntepartum Fetal Surveillance
Antepartum Fetal SurveillanceHale Teka Raya
 
CTG: Interpretation and management
CTG: Interpretation and management CTG: Interpretation and management
CTG: Interpretation and management Aboubakr Elnashar
 
Cardiotocography: CTG antepartum and intrapartum
Cardiotocography: CTG antepartum and intrapartumCardiotocography: CTG antepartum and intrapartum
Cardiotocography: CTG antepartum and intrapartumAboubakr Elnashar
 
Antenatal fetal monitoring
Antenatal fetal   monitoringAntenatal fetal   monitoring
Antenatal fetal monitoringMahmoud zakherah
 
Instrumental vaginaldelivery...
Instrumental  vaginaldelivery...Instrumental  vaginaldelivery...
Instrumental vaginaldelivery...imanswati
 
Antepartum fetal surveillance
Antepartum fetal surveillanceAntepartum fetal surveillance
Antepartum fetal surveillanceJason Zachariah
 
Partogram by Dr Uttara Gupta
Partogram by Dr Uttara GuptaPartogram by Dr Uttara Gupta
Partogram by Dr Uttara GuptaUttara Gupta
 
How to read a CTG دكتور صلاح رزق.pptx
How to read a CTG دكتور صلاح رزق.pptxHow to read a CTG دكتور صلاح رزق.pptx
How to read a CTG دكتور صلاح رزق.pptxSalahRezk
 
Decreased fetal movements
Decreased fetal movementsDecreased fetal movements
Decreased fetal movementsAhmad Saber
 
Intrapartum fetal monitering
Intrapartum fetal moniteringIntrapartum fetal monitering
Intrapartum fetal moniteringdrmcbansal
 

Tendances (20)

CTG Interpretation .pptx
CTG Interpretation .pptxCTG Interpretation .pptx
CTG Interpretation .pptx
 
Cardiotocography
CardiotocographyCardiotocography
Cardiotocography
 
Antepartum Fetal Surveillance
Antepartum Fetal SurveillanceAntepartum Fetal Surveillance
Antepartum Fetal Surveillance
 
CTG: Interpretation and management
CTG: Interpretation and management CTG: Interpretation and management
CTG: Interpretation and management
 
Intrapartum fetal assessment
Intrapartum fetal assessmentIntrapartum fetal assessment
Intrapartum fetal assessment
 
Abnormal CTG
Abnormal CTGAbnormal CTG
Abnormal CTG
 
Fetal surveillance 2020
Fetal surveillance 2020Fetal surveillance 2020
Fetal surveillance 2020
 
Cardiotocography: CTG antepartum and intrapartum
Cardiotocography: CTG antepartum and intrapartumCardiotocography: CTG antepartum and intrapartum
Cardiotocography: CTG antepartum and intrapartum
 
Intrapartum fetal surveillance
Intrapartum   fetal surveillanceIntrapartum   fetal surveillance
Intrapartum fetal surveillance
 
CTG
CTGCTG
CTG
 
Antenatal fetal monitoring
Antenatal fetal   monitoringAntenatal fetal   monitoring
Antenatal fetal monitoring
 
Instrumental vaginaldelivery...
Instrumental  vaginaldelivery...Instrumental  vaginaldelivery...
Instrumental vaginaldelivery...
 
Ctg 2016
Ctg 2016Ctg 2016
Ctg 2016
 
08 ctg isam ws
08 ctg isam ws08 ctg isam ws
08 ctg isam ws
 
Cardiotocography
Cardiotocography Cardiotocography
Cardiotocography
 
Antepartum fetal surveillance
Antepartum fetal surveillanceAntepartum fetal surveillance
Antepartum fetal surveillance
 
Partogram by Dr Uttara Gupta
Partogram by Dr Uttara GuptaPartogram by Dr Uttara Gupta
Partogram by Dr Uttara Gupta
 
How to read a CTG دكتور صلاح رزق.pptx
How to read a CTG دكتور صلاح رزق.pptxHow to read a CTG دكتور صلاح رزق.pptx
How to read a CTG دكتور صلاح رزق.pptx
 
Decreased fetal movements
Decreased fetal movementsDecreased fetal movements
Decreased fetal movements
 
Intrapartum fetal monitering
Intrapartum fetal moniteringIntrapartum fetal monitering
Intrapartum fetal monitering
 

Similaire à CTG: Antepartum

Antepartum Fetal Surveillance.pptx
Antepartum Fetal Surveillance.pptxAntepartum Fetal Surveillance.pptx
Antepartum Fetal Surveillance.pptxestelaabera
 
Antepartum Fetal Surveillance.pptx
Antepartum Fetal Surveillance.pptxAntepartum Fetal Surveillance.pptx
Antepartum Fetal Surveillance.pptxestelaabera
 
Diagnositcs day 2 review
Diagnositcs day 2 reviewDiagnositcs day 2 review
Diagnositcs day 2 reviewcslonern
 
Emergency ultrasonography in 2nd 3rd timester
Emergency ultrasonography in 2nd 3rd timesterEmergency ultrasonography in 2nd 3rd timester
Emergency ultrasonography in 2nd 3rd timesterAboubakr Elnashar
 
Antepartum testing
Antepartum testingAntepartum testing
Antepartum testingDebbie Fritz
 
Antepartum and intrapartum foetal monitoring
Antepartum and intrapartum foetal monitoringAntepartum and intrapartum foetal monitoring
Antepartum and intrapartum foetal monitoringrajeev sood
 
Cardiotocography
Cardiotocography Cardiotocography
Cardiotocography Sana Lodhi
 
Antenatal assessment physical well being /introduction and methods
Antenatal assessment physical well   being /introduction and methodsAntenatal assessment physical well   being /introduction and methods
Antenatal assessment physical well being /introduction and methodsBabitha Mathew
 
antepartum fetal assessment
antepartum fetal assessmentantepartum fetal assessment
antepartum fetal assessmentYohannes Wolde
 
Electronic Fetal Heart Rate Monitoring for Nursing students
Electronic Fetal Heart Rate Monitoring for Nursing studentsElectronic Fetal Heart Rate Monitoring for Nursing students
Electronic Fetal Heart Rate Monitoring for Nursing studentsEman Mohamed
 
Biophysical profile ppt.pptx
Biophysical profile ppt.pptxBiophysical profile ppt.pptx
Biophysical profile ppt.pptxitisha prasad
 
Fetal surveillance
Fetal surveillanceFetal surveillance
Fetal surveillancemaricar chua
 
BIOPHYSICAL PRO.pptx
BIOPHYSICAL PRO.pptxBIOPHYSICAL PRO.pptx
BIOPHYSICAL PRO.pptxAyushi958023
 
4. FETAL SURVEILENCE AND INTRAPARTUM FETAL MONITORING - Copy.pptx
4. FETAL SURVEILENCE AND INTRAPARTUM FETAL MONITORING - Copy.pptx4. FETAL SURVEILENCE AND INTRAPARTUM FETAL MONITORING - Copy.pptx
4. FETAL SURVEILENCE AND INTRAPARTUM FETAL MONITORING - Copy.pptxDrHafashimanaEmmanue
 

Similaire à CTG: Antepartum (20)

Antepartum Fetal Surveillance.pptx
Antepartum Fetal Surveillance.pptxAntepartum Fetal Surveillance.pptx
Antepartum Fetal Surveillance.pptx
 
Antepartum Fetal Surveillance.pptx
Antepartum Fetal Surveillance.pptxAntepartum Fetal Surveillance.pptx
Antepartum Fetal Surveillance.pptx
 
Diagnositcs day 2 review
Diagnositcs day 2 reviewDiagnositcs day 2 review
Diagnositcs day 2 review
 
Dysfunctional labor
Dysfunctional laborDysfunctional labor
Dysfunctional labor
 
Emergency ultrasonography in 2nd 3rd timester
Emergency ultrasonography in 2nd 3rd timesterEmergency ultrasonography in 2nd 3rd timester
Emergency ultrasonography in 2nd 3rd timester
 
Antepartum testing
Antepartum testingAntepartum testing
Antepartum testing
 
Antepartum fetal surveillance
Antepartum fetal surveillanceAntepartum fetal surveillance
Antepartum fetal surveillance
 
Antepartum and intrapartum foetal monitoring
Antepartum and intrapartum foetal monitoringAntepartum and intrapartum foetal monitoring
Antepartum and intrapartum foetal monitoring
 
Cardiotocography
Cardiotocography Cardiotocography
Cardiotocography
 
Antenatal assessment physical well being /introduction and methods
Antenatal assessment physical well   being /introduction and methodsAntenatal assessment physical well   being /introduction and methods
Antenatal assessment physical well being /introduction and methods
 
BIO.pptx
BIO.pptxBIO.pptx
BIO.pptx
 
antepartum fetal assessment
antepartum fetal assessmentantepartum fetal assessment
antepartum fetal assessment
 
CTG Monitoring
CTG MonitoringCTG Monitoring
CTG Monitoring
 
Electronic Fetal Heart Rate Monitoring for Nursing students
Electronic Fetal Heart Rate Monitoring for Nursing studentsElectronic Fetal Heart Rate Monitoring for Nursing students
Electronic Fetal Heart Rate Monitoring for Nursing students
 
Biophysical profile ppt.pptx
Biophysical profile ppt.pptxBiophysical profile ppt.pptx
Biophysical profile ppt.pptx
 
Decreased foetal movements
Decreased foetal movementsDecreased foetal movements
Decreased foetal movements
 
Fetal_Monitoring.pptx
Fetal_Monitoring.pptxFetal_Monitoring.pptx
Fetal_Monitoring.pptx
 
Fetal surveillance
Fetal surveillanceFetal surveillance
Fetal surveillance
 
BIOPHYSICAL PRO.pptx
BIOPHYSICAL PRO.pptxBIOPHYSICAL PRO.pptx
BIOPHYSICAL PRO.pptx
 
4. FETAL SURVEILENCE AND INTRAPARTUM FETAL MONITORING - Copy.pptx
4. FETAL SURVEILENCE AND INTRAPARTUM FETAL MONITORING - Copy.pptx4. FETAL SURVEILENCE AND INTRAPARTUM FETAL MONITORING - Copy.pptx
4. FETAL SURVEILENCE AND INTRAPARTUM FETAL MONITORING - Copy.pptx
 

Plus de Aboubakr Elnashar

WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGISTWHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGISTAboubakr Elnashar
 
Adenomyosis associated infertility
Adenomyosis associated  infertilityAdenomyosis associated  infertility
Adenomyosis associated infertilityAboubakr Elnashar
 
Endometriosis associated infertility: ESHRE2022
Endometriosis associated infertility: ESHRE2022Endometriosis associated infertility: ESHRE2022
Endometriosis associated infertility: ESHRE2022Aboubakr Elnashar
 
Aesthetic gynecology controversy
Aesthetic gynecology controversyAesthetic gynecology controversy
Aesthetic gynecology controversyAboubakr Elnashar
 
Hormonal assay in clinical gyn
Hormonal assay in clinical gynHormonal assay in clinical gyn
Hormonal assay in clinical gynAboubakr Elnashar
 
Unnecessary investigations in reproductive medicine
Unnecessary investigations in reproductive medicineUnnecessary investigations in reproductive medicine
Unnecessary investigations in reproductive medicineAboubakr Elnashar
 
Individualisation of controlled ovarian stimulation
Individualisation of controlled ovarian stimulationIndividualisation of controlled ovarian stimulation
Individualisation of controlled ovarian stimulationAboubakr Elnashar
 
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA Aboubakr Elnashar
 
cesarean birth: procedural aspects: NICE2021
cesarean birth: procedural aspects: NICE2021  cesarean birth: procedural aspects: NICE2021
cesarean birth: procedural aspects: NICE2021 Aboubakr Elnashar
 
Management of pregnancy of unknown location
Management of pregnancy of unknown locationManagement of pregnancy of unknown location
Management of pregnancy of unknown locationAboubakr Elnashar
 
COVID 19 infection and pregnancy RCOG2021
COVID 19 infection and pregnancy RCOG2021COVID 19 infection and pregnancy RCOG2021
COVID 19 infection and pregnancy RCOG2021Aboubakr Elnashar
 

Plus de Aboubakr Elnashar (20)

WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGISTWHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
 
hepatitis B.pdf
hepatitis B.pdfhepatitis B.pdf
hepatitis B.pdf
 
hepatitis c2022.pdf
hepatitis c2022.pdfhepatitis c2022.pdf
hepatitis c2022.pdf
 
Adenomyosis associated infertility
Adenomyosis associated  infertilityAdenomyosis associated  infertility
Adenomyosis associated infertility
 
Endometriosis associated infertility: ESHRE2022
Endometriosis associated infertility: ESHRE2022Endometriosis associated infertility: ESHRE2022
Endometriosis associated infertility: ESHRE2022
 
Adenxal mass guidelines2020
Adenxal mass guidelines2020Adenxal mass guidelines2020
Adenxal mass guidelines2020
 
Aesthetic gynecology controversy
Aesthetic gynecology controversyAesthetic gynecology controversy
Aesthetic gynecology controversy
 
Hormonal assay in clinical gyn
Hormonal assay in clinical gynHormonal assay in clinical gyn
Hormonal assay in clinical gyn
 
FIRST TRIMESTER ANC OF IVF
FIRST TRIMESTER ANC OF IVFFIRST TRIMESTER ANC OF IVF
FIRST TRIMESTER ANC OF IVF
 
Unnecessary investigations in reproductive medicine
Unnecessary investigations in reproductive medicineUnnecessary investigations in reproductive medicine
Unnecessary investigations in reproductive medicine
 
Infertility prevention
Infertility prevention Infertility prevention
Infertility prevention
 
Individualisation of controlled ovarian stimulation
Individualisation of controlled ovarian stimulationIndividualisation of controlled ovarian stimulation
Individualisation of controlled ovarian stimulation
 
Female infertility
Female infertility Female infertility
Female infertility
 
Maternal near miss
Maternal near missMaternal near miss
Maternal near miss
 
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
 
cesarean birth: procedural aspects: NICE2021
cesarean birth: procedural aspects: NICE2021  cesarean birth: procedural aspects: NICE2021
cesarean birth: procedural aspects: NICE2021
 
CAESAREAN SCAR DEFECT
CAESAREAN SCAR DEFECT  CAESAREAN SCAR DEFECT
CAESAREAN SCAR DEFECT
 
Management of pregnancy of unknown location
Management of pregnancy of unknown locationManagement of pregnancy of unknown location
Management of pregnancy of unknown location
 
Aerobic Vaginitis
Aerobic Vaginitis Aerobic Vaginitis
Aerobic Vaginitis
 
COVID 19 infection and pregnancy RCOG2021
COVID 19 infection and pregnancy RCOG2021COVID 19 infection and pregnancy RCOG2021
COVID 19 infection and pregnancy RCOG2021
 

Dernier

97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAAjennyeacort
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseSreenivasa Reddy Thalla
 
maternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalitymaternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalityhardikdabas3
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranTara Rajendran
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsMedicoseAcademics
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfSasikiranMarri
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptMumux Mirani
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxKezaiah S
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxdrashraf369
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMADivya Kanojiya
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxEyobAlemu11
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 

Dernier (20)

97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies Disease
 
maternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalitymaternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortality
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.ppt
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptx
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptx
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 

CTG: Antepartum

  • 3. Patterns of foetal activity 1.Fetal breathing movements 2.Gross body movements 3.Fine motor movements Aboubakr Elnashar
  • 4. During the last 10 w of pregnancy: F. breathing movements: 30% of the time Gross body movements: 10% of the time At term: Cycling between activity & quiescence: occurs over a time span of 60 min Activity is highest: in late evening FHR variation: increases during fetal activity f. body movements: FH acceleration Aboubakr Elnashar
  • 5. Adaptations to hypoxia  Early 1.Reduced FHR reactivity 2.Absence of breathing movements  Late: 1. Reduced body movements and tone 2. Reduced liquor (renal hypoperfusion) Aboubakr Elnashar
  • 7. The ideal test 1. Quick 2. Easy to perform 3. Interpreted results that are reproducible. 4. Clearly identify the compromised fetus at a stage at which intervention will improve the outcome 5. Not give an abnormal result for a healthy fetus.  Unfortunately, this ideal test does not yet exist! Aboubakr Elnashar
  • 8. I. Fetal movements counting (FMC) II. FHR recording 1.CTG 2.Non-Stress Test (NST) 3.Contraction StressTest (CST) or Oxytocin Challenge Test (OCT) 4.Nipple stimulation test 5.Vibroacoustic stimulation (VAS) 6.Computerized CTG III. Biophysical Profile (BPP) IV. Doppler Aboubakr Elnashar
  • 9. FHR recording 1.CTG 2.NST 3.Contraction stress test 4.Nipple stimulation test 5.Acoustic stimulation test 6.Computerized CTG Aboubakr Elnashar
  • 10. 1. FHR tracings (CTG) METHOD Simultaneous recordings are performed by 2 separate transducers: 1st for FHR 2nd for UC Aboubakr Elnashar
  • 11. INTERPRETATION 1.Normal/Reassuring Trace  Baseline FHR: 110-150 b/m  Baseline variability: 10- 25 b/m  At least 2 accelerations (>15 beats for> 15 sec in 20 min)  No decelerations. Aboubakr Elnashar
  • 12. 2. Suspicious/Equivocal Trace.  Baseline FHR: 150-170 b/m or 100-110 b/m  Reduced baseline variability (5-10 b/m for >40 m)  Absence of accelerations for >40 m  Sporadic deceleration of any type.  absence of accelerations  diminished variability  late decelerations with weak spontaneous contractions. Aboubakr Elnashar
  • 14. Abnormal/Pathological Trace -  Baseline FHR: <100 b/m or > 170 b/m  No area of normal baseline variability  Silent Pattern (<5 b/m) for >40 min  Sinusoidal pattern (oscillation frequency = 2-5 cycles/min, amplitude of 5-15 b/m) for >40 m  No accelerations  Repeated late, prolonged (> 1 minute) severe variable* (>40 b/m) decelerations.  *decelerations vary in depth, vary in duration and vary in timing relative to the uterine activity Aboubakr Elnashar
  • 15. Tachycardia  Sinusoidal pattern  Late deceleration normal baseline rate at 120 bpm, absent baseline variability, no accelerations late decelerations Aboubakr Elnashar
  • 16.  variable fetal heart rate decelerations. Reassuring shoulders (accelerations) are obvious before and after each deceleration. baseline tachycardia minimal variability. Aboubakr Elnashar
  • 17. MANAGEMENT:  Normal/Reassuring Trace – repeat and/or estimate AFI if considered necessary acc to the cl situation and indication for testing.  Suspicious/Equivocal Trace –  Continue for up to 60 min {determine the presence of f rest/activity cycles}.  Further evaluation acc to the cl situation e.g. fetal acoustic stimulation, AFI, BPP, Doppler blood velocity waveform.  Abnormal/Pathological Trace –  deliver if clinically appropriate.  Further evaluation/monitoring if not appropriate to deliver. Aboubakr Elnashar
  • 18. Advantages: It is the most commonly performed antenatal test for fetal wellbeing. Quick Simple to perform Aboubakr Elnashar
  • 19. 2. The Non-Stress Test (NST) (Hammacher et al, 1960) Idea: • FHR accelerations: linked closely with f movements {increased sympathetic output}. • The long term variability: {balance between sympathetic & parasympathetic tone} • The short term variability (baseline or bandwidth variability) {parasympathetic tone}. Aboubakr Elnashar
  • 20. Steps: 1. left lateral recumbent position. 2. Place and adjust the external tocodynamometer and US transducer to obtain the best possible tracing. 3. Instruct the patient to record f movements on the monitor tracing using the event marker. 4. Observe the EFM tracing until the criteria for a reactive test are met (minimum of 20 min and maximum of 60 min). Aboubakr Elnashar
  • 21.  In the event of lack of f movement, apply stimulation e.g. fetal acoustic stimulator.  Record any relevant clinical information on the EFM tracing e.g. BP T P loss of contact changes in maternal position. Aboubakr Elnashar
  • 22. Interpretation:  Reactive: 2 accelerations of FHR in 20 min. Each acceleration 15 beat & lasts 15 sec.  Non-reactive: no accelerations in 40 min. Aboubakr Elnashar
  • 23. •Reactive: increase of FHR to >15 beats/min for > 15 sec following fetal movements Reactive Aboubakr Elnashar
  • 24. Antenatal maternal glucose administration: not to reduce non-reactive CTG (Cochrane , 2001) Manual fetal manipulation: not to reduce the incidence of non-reactive CTG. (Cochrane , 2001) Reactive nonstress reliable screening indicator of f wellbeing in women presenting with perception of RFM in 3rd T Abnormal pregnancy outcomes: more common when initial CTG was non reactive (Daly et al, 2011) Aboubakr Elnashar
  • 25. Disadvantages: 1. Interpretation may be difficult & poor agreement between experts in assessing CTG 2. The predictive value of an abnormal NST for perinatal morbidity & mortality:<40% (Devoe et al, 1985) Aboubakr Elnashar
  • 26. 3. No significant effect on perinatal outcome (MA of 13 trials) Trend towards increased perinatal mortality (SR of 4 RCT) (Cochrane library, 2001) NST should not be relied upon as the sole means of establishing f wellbeing {Ia} Aboubakr Elnashar
  • 27. 3. The Contraction Stress Test (CST) or Oxytocin Challenge Test (OCT) 1972: First introduced by Ray 1975: Freeman introduced the parameters of contraction number and frequency to standardize the test. Aboubakr Elnashar
  • 28. Idea: It is a test of the uteroplacental unit. If fetal oxygenation is marginal at rest, it will transiently worsen with uterine contractions: hypoxemia: late decelerations. If variable decelerations were seen, one should suspect oligohydramnios. Aboubakr Elnashar
  • 29. Steps: Semi-fowlers position. If the patient is not having spontaneous contractions, pitocin is begun at 0.5-1.0 mU and increased /15-20 minutes until 3C/10 min. Aboubakr Elnashar
  • 30. Interpretation: Negative: no decelerations with the 3 contractions in the 10 minute window. Positive: late decelerations with 50% or more of the contractions. Suspicious: intermittent late decelerations or severe variable deceleration. Unsatisfactory: <3 contractions or hyperstimulation. Aboubakr Elnashar
  • 31. •Non-reactive NST followed by CST: mild late decelerations. Aboubakr Elnashar
  • 33. 1. Negative No deceleration 2. Positive transient decelerations Aboubakr Elnashar
  • 34. Relative contraindications: 1. Preterm labor or certain patients at high risk of preterm labor 2. Preterm membrane rupture 3. History of extensive uterine surgery or classical cesarean delivery 4. Known placenta previa Aboubakr Elnashar
  • 35. The role of this technique has yet to be established it has been associated with reports of fetal death in cases of unrecognized severe fetal compromise [E]. Aboubakr Elnashar
  • 36. Sequence Of Events With Placental Insufficiency or Hypoxia 1. Positive CST= late deceleration in 50% of UC. 2. Non reactive NST= No HR acceleration 3. Cessation of fetal movement 4. Basal line tachycardia > 160 bpm 5. Basal line bradycardia <110 bpm Aboubakr Elnashar
  • 37. 5. VIBROACOUSTIC STIMULATION (VAS) Idea: Vibroacoustic stimulator wakes a sleeping fetus: changing its behavioral state. How to perform: Artificial larynxes that generate sound pressure levels of approximately 80 to 100 decibels is applied in two or three one-second bursts to the maternal abdomen near the fetal head. Aboubakr Elnashar
  • 38. Advantages: 1. Easy, relatively inexpensive way to shorten testing times and reduce the false-positive rates for NST & biophysical profiles. 2. Fetuses that respond to VAS with an acceleration on NST or a startle response on FBP: very low rates of death within one week of the test. 3. Decrease the incidence of non- reactive CTG and reducing the testing time (The Cochrane Database of Systematic Review, 2001) Aboubakr Elnashar
  • 39. 6. Computerized CTG • To improve the objectivity of antenatal CTG • The program unlike conventional CTG, allows measurement of short term variability (STV). • STV=variation measured in 3.75 s epochs. • FHRV: better predictor of fetal compromise than the acceleration or decelerations. • Likelihood of metabolic acidaemia or IUFD can be calculated according to the STV. Aboubakr Elnashar
  • 41. Conventional Vs computerized CTG 1.Fewer additional fetal tests 2.Less time in testing. 3.The study was not large enough to demonstrate any effect on perinatal morbidity or mortality. Aboubakr Elnashar
  • 42. III. The Biophysical Profile (BPP) First described by Manning in 1980. Idea: Sequence of fetal deterioration 1. Late decelerations appear (CST) 2. Accelerations disappear (NST, BPP, CST) 3. F breathing stops (BPP) 4. F movement stops (BPP) 5. F tone absent (BPP) 6. A F decreases {chronic hypoxia: redistribution of cardiac output away from the kidneys toward the brain}: AFV is a quick evaluation of long term uteroplacental function as in the late 2nd and all the 3rd trimester {AF is essentially fetal urine}. Aboubakr Elnashar
  • 43. OBSERVATION CRITERIA FOR PRESENT CRITERIA FOR NEGATIVE F Tone 1 episode of flexion- extension-flexion in 30 min No episodes of flexion- extension-flexion in 30 minutes F Movement 3 gross body movements in 30 min Less than 3 gross body movements in 30 minutes F Breathing 1 episode of rhythmic breathing in 30 min No episodes of rhythmic breathing in 30 minutes A FV One 2 centimeter pocket measured in two perpendicular planes A pocket measuring less than 2 centimeters NST Reactive test Non-reactive test Two points are given if the observation is present and zero points are given if it is absent. Aboubakr Elnashar
  • 44. Interpretation: 8: reassuring. 6: equivocal: repeat within 24 h. 4 or less: positive test: strongly suggests preparing the patient for delivery. Aboubakr Elnashar
  • 45. Modifications 1. BPP Manning (1990) NST AFV Fetal breathing. less cumbersome results are just as predictive. Aboubakr Elnashar
  • 46. 2. Placental grading has been incorporated in the BPP to give an overall score out of 12 rather than 10. Aboubakr Elnashar
  • 47. 3. The most powerful components: •AFI: indicator of long term uteroplacental function •NST: short term indicator of fetal acid-base status. assessment of fetal well-being using these two tools alone may well be as effective as formal BPP Aboubakr Elnashar
  • 48.  Advantages: 1. In high-risk:  observational studies: effective  {good negative predictive value (99.9%) i.e. fetal death is rare in women with a normal FBP  rarely abnormal when Doppler findings were normal}. Aboubakr Elnashar
  • 49. 2. In pre-labour rupture of the membranes {fetal breathing movements is reduced in the presence of chorioamnionitis} But sensitivity for abnormal BPP in the presence of chorioamnionitis is 25%[B]: value of BPP is limited Aboubakr Elnashar
  • 50.  Disadvantages: 1. Difficult and time-consuming 2. False-positive rate: 70%: increased rates of unnecessary intervention. 3. Systematic review of five RCTs: failed to demonstrate any significant benefit of BPP on pregnancy outcome when compared to NST Aboubakr Elnashar
  • 51. 4. In low risk: cannot be recommended for routine monitoring 5. In high Risk: positive predictive value of 35% (observational study) No enough evidence from RCTs (Cochrane Systematic Review, 2000).: cannot be recommended for routine monitoring for primary surveillance in SGA Aboubakr Elnashar
  • 52. Statistical Characteristics of Selected Antepartum Fetal Tests Characteristic NST CST BPP Specificity Poor Average High Specificity High High High False-positive rate High High High False-negative rate Low Low Average Aboubakr Elnashar
  • 54. 1. CTG, must not form the sole basis for the assessment of the fetus. 2. Computerized CTG may well be more effective than standard CTG. 3. Formal assessment of the BPP does not appear to hold any advantage over assessment of liquor volume alone. 4. Where fetal growth restriction is suspected, fetal biometry and assessment of umbilical artery waveforms by Doppler ultrasonography should be incorporated. Aboubakr Elnashar